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Dear Editor,
Without downgrading the histological assessment of 
liver  fibrosis,  efforts  are  being  made  to  develop  accu-
rate and reliable non-invasive indices as alternatives to 
liver biopsy. Previously proposed panels of liver fibrosis 
usually include 2 to  7 blood markers. The majority of 
publications were concerned with liver fibrosis among 
patients with chronic hepatitis C (CHC). However, few 
studies have assessed drug-mediated liver fibrogenesis, 
non-alcoholic  fatty  liver  disease  (NAFLD),  Schistosoma 
mansoni-induced  liver  fibrosis,  and  hepatitis  B  virus-
related liver fibrosis. In the work entitled “Noninvasive 
assessment of liver fibrosis with the aspartate transami-
nase to platelet ratio index (APRI): Usefulness in patients 
with chronic liver disease,” (1) authors have investigated 
207  patients  with  chronic  hepatitis  B  (CHB),  108  with 
CHC, and 140 with NAFLD. In this study, the APRI score (2) 
was calculated and matched with the histological stages 
of  fibrosis  using  the  METAVIR  scale.  Additionally,  they 
employed the Kleiner system for grading the extent of 
fibrosis in NAFLD patients.
The authors came to the conclusion that APRI was sig-
nificantly associated with fibrosis score in patients with 
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CHC and NAFLD, but not in patients with CHB. However, 
some reports showed a significant correlation between 
fibrosis scores and APRI in Chinese (3) and Korean (4) 
patients with CHB. Although Yilmaz et al. (1) tried to ex-
plain the application of APRI in the assessment of he-
patic fibrosis induced by different agents, they enhanced 
the contradictions and the misconceptions about using 
noninvasive markers implicated in the different indices. 
Previously reported indices have combined 1 (or more) 
variable of the following 4 categories: (i) extracellular 
matrix (ECM) proteins or enzymes (such as laminin, col-
lagen, lysyl oxidase, prolyl hydroxylase, hyalauronic acid, 
or TIMP-1) which are known to play a role in scar forma-
tion, degradation, or activation of hepatic stellate cells 
(HSC)  ;  (ii)  liver-specific  markers  (bilirubin,  transami-
nases, or globulin); (iii) hematological variables (plate-
lets or PT); and (iv) conjugated or derived lipids (such 
as:  apolipoprotein  and  cholesterol).  Recently,  we  com-
bined reduced glutathione (GSH) as an oxidative stress 
marker (5) along with total bilirubin, gamma glutamyl 
transpeptidase (gGT), and total proteins. The validated 
index was able to monitor the progression and regres-
sion of fibrosis in fibrotic models generated through ex-
posure to thiacetamide (TAA) and ethanol and infection 
with S. mansoni. Changes in the level of ECM proteins or 
the activity of ECM enzymes reported in some indices 
(6) usually comes next to the initial events of oxidative 
stress-mediated HSC activation. When Novitskiy et al. (7) 
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treated HSC with ethanol, they noticed the formation of 
reactive oxygen species (ROS), which activated HSC and 
promoted fibrogenesis. 
  Consequently,  studies  that  investigate  populations 
with  etiologically  different  liver  fibrosis  may  require 
the use of indices that involve direct fibrogenesis and/
or oxidative stress markers, in addition to liver specific 
markers. The limited number of variables in APRI may 
minimize its potential in monitoring the basic events in 
scar formation, which is the common scenario in etio-
logically  different  fibrosis.  However,  the  contradictory 
outcomes of different studies in the last few years may 
raise the question: Do we need a common liver fibrosis 
index or etiology-related indices?
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